SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

SEARCH LISTED COMPANY


Any AUS or NZ company

BROWSE

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

PALLA PHARMA LIMITED(PAL)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 FROMTO
PALLA PHARMA LIMITED19/06/2019
TPI ENTERPRISES LIMITED19/06/2019

Shareholder links

Our website ranking of PAL: rating 3
(3 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Link Market Services, Tower 4, 727 Collins Street Docklands VIC 3008

Tel : +61 3 9615 9800
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail

Company details

ISIN: AU0000049462
Address: Mertons Corporate Services Level 7, 330 Collins Street Melbourne, Victoria, 3000
Tel:  +61 3 9301 0800 Fax: +61 3 9301 0899

Date first listed: 13/08/2015
Company Secretary: Mark Licciardo
Sector: Pharmaceuticals Biotechnology & Life Sciences Industry Group: XHJ
Activities: Manufacturer of narcotic raw material for supply to the pharmaceutical industry

News & Events

Expand this box to read and print

Since the appointment of the voluntary administrators, a process was commenced seeking proposals for the recapitalisation or sale of all or part of the assets controlled by the Company together with its shareholding in its 100% owned subsidiaries Palla Pharma Norway AS and Palla Pharma UK. In consideration of the limited liquidity available, the Administrators have implemented an appropriate timeframe to undertake the process whilst reserving their rights to change the proposed timetable should circumstances provide. To date the Administrators have undertaken numerous actions to attract interest including: Placed an advertisement in the Australian Financial Review on 29 December 2021 seeking expressions of interest; Written to a number of logical strategic buyers, including key industry players, identified through discussions with management, industry research, and review of books and records of the Company; Contacted several investment funds to determine any interest in the Company and assets for sale and/or recapitalisation. On 12 January 2022, an application was filed in the Federal Court of Australia seeking orders under sections 439A and 447A of the Corporations Act extending the time to convene the second meeting of creditors for a period of up to 90 days to 27 April 2022.

13/01/2022

The Company has entered voluntary administration. Craig Shepard and Bryan Webster of Korda Mentha were appointed as joint and several Voluntary Administrators. The Administrators have assumed control of the Company and will work with the Board during the administration period to maximise the outcome for all stakeholders of the Company.

17/12/2021

The securities of Palla Pharma Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of PAL, pending the release of an announcement regarding the results of the review undertaken by PAL of its strategy and operations.

15/12/2021

name changed from TPI Enterprises Ltd

19/06/2019
OFX Transferring Money Internationally to Free

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    12/04/2021Iain Ross75,000$0.476$35,700
    02/03/2018Peter Robinson25,000$1.360$34,000
    01/09/2017Stuart Black15,000$2.391$35,868
    31/05/2016Jarrod Ritchie1,000$3.100$3,100
    28/10/2015Jarrod Ritchie1,800$3.450$6,210

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Simon MooreChairman01/06/2016
    Giles MossCEO01/09/2021
    Paul ShermanCFO19/10/2021
    Iain RossNon Exec Director23/12/2020
    Stuart BlackNon Exec Director07/06/2016
    Sue MacLemanNon Exec Director27/11/2018

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Brendan MiddletonCFO12/04/201719/10/2021
    Todd BarlowNon Exec Director18/06/201504/02/2021
    Jarrod RitchieManaging Director, CEO05/02/200422/12/2020
    Peter RobinsonChairman01/02/201301/05/2018

    Date of first appointment, title may have changed.